Cas:35493-47-1 2-Tetradecylcyclobutanone manufacturer & supplier

We serve Chemical Name:2-Tetradecylcyclobutanone CAS:35493-47-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Tetradecylcyclobutanone

Chemical Name:2-Tetradecylcyclobutanone
CAS.NO:35493-47-1
Synonyms:2-tetradecylcyclobutan-1-one
Molecular Formula:C18H34O
Molecular Weight:266.46200
HS Code:2914299000

Physical and Chemical Properties:
Melting point:39-43ºC
Boiling point:340.8ºC at 760 mmHg
Density:0.879g/cm3
Index of Refraction:1.463
PSA:17.07000
Exact Mass:266.26100
LogP:6.05670

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:NONH for all modes of transpor
Packing Group:


Contact us for information like 2-tetradecylcyclobutan-1-one chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-tetradecylcyclobutan-1-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2-tetradecylcyclobutan-1-one Use and application,2-tetradecylcyclobutan-1-one technical grade,usp/ep/jp grade.


Related News: Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 2-Tetradecylcyclobutanone manufacturer We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. 2-Tetradecylcyclobutanone supplier Most of California’s COVID-19 restrictions were lifted on Tuesday and the nation’s most populous state is poised to come roaring back,” according to Gov. Gavin Newsom.
State social distancing rules and capacity limits at restaurants, bars, supermarkets, gyms, stadiums and other locations have been rolled back, and masks will no longer be required for vaccinated people in most settings, the Associated Press reported.
However, businesses and counties can still require them.
In March 2020, California became the first in the United States to impose a statewide shutdown. More people tested positive for the virus (3.8 million to date) and more people died (more than 63,000) in California than anywhere else in the country, but it had a lower per capita death rate than most others, the AP reported.
California now has one of the lowest infection rates (below 1%) in the U.S.
That low rate and a rising number of vaccinated residents — over 70% of adults have had at least one shot — led Newsom to announce in April that most pandemic restrictions would be lifted June 15, the AP reported.
However, the governor has repeatedly said the reopening doesn’t mean the pandemic is over, and some public health measures will still be in place for “mega events. 2-Tetradecylcyclobutanone vendor We have leading expertise in strategy and operational implementation of pre-approval access programs making pharmaceutical products under clinical development available for patients and Inceptua��s clinical trial services business offers high quality clinical comparator sourcing and manufacturing services with an agile global supply chain to ensure that products are delivered exactly when needed. 2-Tetradecylcyclobutanone factory Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data.